Clipping of news on Brazilian Culture, Law and Citizenship
 


Consumer News

Kraemer laboratory is forbidden to be considered unsatisfactory for the production of medicines

04/01/2015

This article was translated by an automatic translation system, and was therefore not reviewed by people.




transparent image


ANVISA ordered the suspension, throughout the national territory, manufacturing, distribution, dissemination, marketing and use of all lots and all products manufactured by the company Kraemer Laboratory Ltda.

The company was considered unsatisfactory for the production of drugs to enter at odds with the Good Manufacturing Practices of pharmaceutical products. The company also marketed unregistered products with ANVISA.

The measure is in Resolution No. 980, published on Monday (30/3) in the Official Gazette (DOU). The standard ratified Resolution No. 2,330 / 14 on the subject.

The company will promote the collection of existing stocks in the market.

Check the resolution in the Official Gazette
 



Source: ANVISA

To access the ANVISA site, click here.

Our news are taken in full of our partner sites. For this reason, we can not change their content even in cases of typos. transparent image

This article was translated by an automatic translation system, and was therefore not reviewed by people.

Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.


  Subjects list
 
  Copyright (c) 2006-2009. JurisWay - All rights reserved.